Maryland Cannabis Program: Regulations, Licensing & Market Overview

Executive Summary

Maryland operates one of the nation's most mature adult-use cannabis programs, having transitioned from medical-only access to full recreational legalization on July 1, 2023. The state's cannabis framework emerged from a decade-long evolution that began with limited medical pilot programs in 2014, expanded through legislative reforms, and culminated in voter approval of Question 4 during the November 2022 election. As of May 2026, Maryland hosts over 100 licensed dispensaries, more than 20 cultivation facilities, and has generated over $450 million in cumulative tax revenue since adult-use sales commenced. The program operates under dual regulatory oversight: the Maryland Cannabis Administration (MCA) manages licensing and compliance, while local jurisdictions retain zoning authority. Recent federal rescheduling discussions have prompted state officials to evaluate alignment between Maryland's regulatory framework and evolving DEA guidance, particularly regarding interstate commerce restrictions and banking access. The state's social equity provisions—among the most comprehensive in the nation—allocate 25% of cultivation and processing licenses to applicants from communities disproportionately impacted by prohibition-era enforcement.

Why This Matters

Maryland's cannabis program directly affects 6.2 million residents, employs approximately 8,500 workers, and represents a $1.2 billion annual market as of 2025. The state's approach to legalization serves as a critical case study for mid-Atlantic jurisdictions navigating the transition from prohibition to regulated commerce. For patients, the program maintains separate medical and adult-use pathways, with medical cardholders accessing higher possession limits (120 grams versus 1.5 ounces for recreational users) and lower effective tax rates. Operators face a complex licensing landscape: Maryland caps the total number of cultivation licenses at 150 and processing licenses at 100, creating artificial scarcity that drives license values above $5 million in secondary markets. The program's economic impact extends beyond direct sales. According to the Maryland Department of Commerce, cannabis-related businesses contributed $87 million in wages during fiscal year 2025, with average salaries for cultivation technicians reaching $48,000 annually. Ancillary industries—security, compliance software, packaging, testing laboratories—employ an additional 2,000 workers statewide. For investors, Maryland's market dynamics reflect broader regional trends: multi-state operators (MSOs) control approximately 40% of dispensary licenses through acquisition of local operators, while independent retailers maintain stronger footholds in Baltimore City and Prince George's County. Social equity remains the program's most scrutinized dimension. The MCA's social equity applicant designation requires documentation of residence in a disproportionately impacted area (DIA) for at least five of the past ten years, or proof of a prior cannabis conviction. As of April 2026, social equity licensees operated 18 of Maryland's 102 active dispensaries, below the statutory 25% target. Advocates including the Marijuana Policy Project and the Maryland Cannabis Industry Association have called for expanded technical assistance funding and expedited license processing for equity applicants.

Background and History

Maryland's path to adult-use legalization spans 12 years, beginning with the Natalie M. LaPrade Medical Cannabis Commission's establishment in 2014.

2014–2017: Medical Pilot Program

The Maryland General Assembly passed Senate Bill 923 in 2014, creating a tightly regulated medical cannabis framework named after Natalie M. LaPrade, a medical cannabis advocate who testified extensively before her death in 2015. The legislation authorized up to 15 cultivation licenses and 94 dispensary licenses statewide, with geographic distribution requirements ensuring at least one dispensary per county. Initial qualifying conditions included cachexia, anorexia, wasting syndrome, severe pain, severe nausea, seizures, severe or persistent muscle spasms, and glaucoma. The first dispensary opened in December 2017 in Frederick, three years after enabling legislation passed. Delays stemmed from protracted rulemaking, zoning disputes in conservative jurisdictions, and litigation over the initial license scoring process. The Maryland Court of Special Appeals ruled in Freestate Wellness, LLC v. Natalie M. LaPrade Medical Cannabis Commission (2016) that the Commission must provide detailed scoring justifications for denied applications, establishing precedent for transparency in cannabis licensing nationwide.

2018–2021: Medical Program Expansion

By 2019, Maryland's medical program served 45,000 registered patients through 52 operational dispensaries. The General Assembly expanded qualifying conditions in 2020 to include chronic pain (replacing "severe pain"), PTSD, and any condition for which a physician believes cannabis could provide therapeutic benefit—effectively creating a de facto recommendation system similar to California's pre-legalization framework. House Bill 1453 (2020) increased the cultivation license cap from 15 to 22 and authorized "micro-licenses" for cultivation facilities under 10,000 square feet, aimed at lowering barriers for social equity applicants. The COVID-19 pandemic accelerated telemedicine adoption: by June 2020, over 80% of medical cannabis certifications occurred via telehealth platforms, a shift the MCA made permanent in 2021.

2022: Voter Approval of Adult-Use Legalization

On November 8, 2022, Maryland voters approved Question 4 with 67% support, amending the state constitution to legalize cannabis possession and use for adults 21 and older effective July 1, 2023. The ballot measure required the General Assembly to enact implementing legislation by July 1, 2023, establishing regulatory frameworks, taxation structures, and social equity provisions. Senate Bill 516 and House Bill 556, passed in April 2023, created the Maryland Cannabis Administration as the successor agency to the Medical Cannabis Commission. The legislation established a 9% retail excise tax (in addition to the 6% state sales tax), allocated 35% of cannabis tax revenue to the Community Reinvestment and Repair Fund for expungement services and workforce development in DIAs, and mandated that existing medical dispensaries could begin adult-use sales immediately upon regulatory approval.

2023–Present: Adult-Use Implementation

Adult-use sales commenced on July 1, 2023, with 94 dispensaries authorized for dual licensing. First-month sales reached $72 million, exceeding projections by 40%. By December 2023, the MCA had issued 12 new adult-use-only dispensary licenses through a lottery system weighted toward social equity applicants. In January 2025, the General Assembly passed House Bill 822, which removed the cultivation license cap for social equity applicants and established a $10 million revolving loan fund administered by the Maryland Department of Commerce. The legislation also created an "on-site consumption" license category, permitting cannabis lounges in jurisdictions that opt in via local ordinance. As of May 2026, only Baltimore City and Takoma Park have authorized consumption lounges, with three facilities operational.

Key Players

Maryland Cannabis Administration (MCA)

The MCA, established July 1, 2023, operates as an independent unit within the Maryland Department of Health. The agency employs 87 full-time staff and maintains a $14 million annual operating budget funded through license fees. Executive Director Cynthia Boersma, appointed in August 2023, previously served as deputy director of Colorado's Marijuana Enforcement Division. The MCA oversees all licensing, compliance inspections (averaging 220 per month), laboratory testing standards, and social equity program administration.

Multi-State Operators

Trulieve Cannabis Corp. operates 11 Maryland dispensaries under the Harvest brand following its 2021 acquisition of Harvest Health & Recreation. Curaleaf Holdings operates eight locations statewide. Verano Holdings maintains six dispensaries and one cultivation facility in Hagerstown. These MSOs collectively control approximately 25% of Maryland's retail market share, according to BDSA analytics data from Q4 2025.

Social Equity Advocates

The Maryland Cannabis Industry Association (MdCIA), founded in 2018, represents over 140 licensed businesses and advocates for regulatory streamlining and expanded license availability. The Marijuana Policy Project maintains a Maryland-focused lobbying operation that successfully pushed for automatic expungement provisions in the 2023 implementing legislation. The ACLU of Maryland publishes quarterly reports tracking racial disparities in cannabis enforcement, noting that Black Marylanders were arrested for cannabis possession at 2.8 times the rate of white residents during the final year of prohibition (2022), despite similar usage rates.

Opposition and Regulatory Skeptics

Smart Approaches to Marijuana (SAM) maintains a Maryland chapter that testified against Question 4 in 2022, citing concerns about impaired driving and youth access. The Maryland State Police coordinates with the MCA on impaired driving enforcement, reporting 340 cannabis-related DUI arrests in 2024, up from 180 in 2022. The Maryland Chiefs of Police Association has called for increased funding for Advanced Roadside Impaired Driving Enforcement (ARIDE) training, which 68% of Maryland law enforcement officers had completed as of March 2026.

Legal and Regulatory Framework

Maryland's cannabis program operates under constitutional authority granted by the 2022 amendment to Article XX of the Maryland Constitution, implemented through Title 36 of the Maryland Code. Maryland Code, Health-General Article § 36-101 et seq. establishes the MCA's regulatory authority, license categories, and enforcement mechanisms. The statute differentiates between medical cannabis (governed by § 36-201 through § 36-301) and adult-use cannabis (§ 36-401 through § 36-501).

Possession and Cultivation Limits

Adults 21 and older may possess up to 1.5 ounces (42.5 grams) of cannabis flower or 12 grams of concentrated cannabis. Medical cannabis patients with valid MCA registration cards may possess up to 120 grams per 30-day period, as certified by their physician. Home cultivation remains prohibited for both medical and adult-use consumers—Maryland is one of seven adult-use states maintaining this restriction, alongside Washington, New Jersey, Illinois, Delaware, Connecticut, and New York.

Licensing Structure

Maryland issues six primary license types:

• Cultivation (Tier 1): Facilities up to 50,000 square feet canopy; initial license fee $10,000, annual renewal $40,000
• Cultivation (Tier 2): Facilities 50,001–150,000 square feet; initial fee $20,000, renewal $80,000
• Processing: Extraction, infusion, and manufacturing; initial fee $10,000, renewal $40,000
• Dispensary: Retail sales; initial fee $5,000, renewal $20,000
• Testing Laboratory: Independent third-party analysis; initial fee $10,000, renewal $40,000
• On-Site Consumption: Cannabis lounges (authorized January 2025); initial fee $5,000, renewal $15,000

The MCA conducts license application periods biannually, with social equity applicants receiving scoring advantages: 10 additional points (on a 100-point scale) for DIA residence, 15 points for prior cannabis convictions, and 5 points for veteran status.

Taxation

Maryland imposes a 9% excise tax on gross retail sales, collected at the point of sale and remitted monthly to the Comptroller of Maryland. This is in addition to the state's 6% sales tax, resulting in a 15% total tax burden (excluding local sales taxes, which range from 0% to 3.2% depending on jurisdiction). Medical cannabis patients pay only the 6% sales tax, exempting them from the 9% excise tax. Tax revenue allocation follows a statutory formula:

• 35% to the Community Reinvestment and Repair Fund
• 25% to the Public Health Fund for substance abuse treatment
• 15% to the Cannabis Business Assistance Fund for social equity loans
• 10% to the MCA operating budget
• 15% to the state General Fund

Federal Conflicts and Banking

Maryland-licensed cannabis businesses remain subject to federal prohibition under the Controlled Substances Act, 21 U.S.C. § 812, which classifies cannabis as a Schedule I substance. This classification creates banking access challenges: as of April 2026, only 12 Maryland-chartered banks and credit unions serve cannabis clients, requiring operators to maintain cash-intensive operations. The pending federal rescheduling to Schedule III, anticipated by Q3 2026 according to DEA guidance published in April 2026, would not resolve the fundamental illegality under federal law but could eliminate Internal Revenue Code § 280E restrictions, which currently prohibit cannabis businesses from deducting ordinary business expenses.

State-by-State Context: Maryland in the Regional Landscape

Maryland's program exists within a rapidly evolving mid-Atlantic cannabis corridor, with neighboring jurisdictions at varying stages of legalization.

Maryland

Status: Adult-use legal since July 1, 2023. Possession limit: 1.5 ounces. Home cultivation: prohibited. Active dispensaries: 102 (as of May 2026). 2025 sales: $1.2 billion. Tax rate: 15% total (9% excise + 6% sales).

Virginia

Status: Adult-use legal since July 1, 2021, but retail sales not yet operational as of May 2026. Possession limit: 1 ounce. Home cultivation: allowed (4 plants per household). Virginia's delayed retail implementation has driven cross-border traffic to Maryland dispensaries in Northern Virginia suburbs, with MCA data showing 18% of transactions at dispensaries within 10 miles of the Virginia border involve out-of-state IDs.

Delaware

Status: Adult-use legal since April 23, 2023 (retail sales began January 2024). Possession limit: 1 ounce. Home cultivation: prohibited. Delaware's smaller market (population 1 million versus Maryland's 6.2 million) and higher effective tax rate (15% excise + 0% sales tax = 15% total, but with higher per-gram wholesale taxes) have limited competitive pressure on Maryland's Eastern Shore dispensaries.

Pennsylvania

Status: Medical-only as of May 2026. Adult-use legalization bills have stalled in the Republican-controlled state Senate since 2023. Pennsylvania's medical program serves 450,000 registered patients, with significant cross-border purchasing in Maryland's Washington and Frederick counties. Pennsylvania residents accounted for 12% of Maryland dispensary transactions in Q1 2026, according to MCA point-of-sale data.

West Virginia

Status: Medical-only, with the first dispensary opening in November 2021. Adult-use legalization remains politically unlikely. West Virginia's restrictive medical program (requiring in-person physician consultations and limiting qualifying conditions) drives patients to Maryland's Garrett and Allegany county dispensaries.

Washington, D.C.

Status: Adult-use possession and home cultivation legal since 2015, but retail sales remain prohibited due to congressional budget riders. D.C.'s "gifting economy"—where businesses sell non-cannabis products and "gift" cannabis—operates in legal gray areas. Maryland dispensaries in Prince George's and Montgomery counties derive approximately 30% of revenue from D.C. residents, according to industry surveys conducted by the MdCIA in 2025.

Market and Business Implications

Maryland's cannabis market generated $1.2 billion in retail sales during 2025, with wholesale prices stabilizing after initial post-legalization volatility.

Wholesale Pricing Dynamics

Average wholesale prices for cannabis flower declined from $2,800 per pound in July 2023 to $1,400 per pound by December 2025, according to LeafLink transaction data. This 50% price compression reflects increased cultivation capacity: Maryland's total licensed canopy grew from 1.2 million square feet in mid-2023 to 2.1 million square feet by early 2026. Processors reported wholesale concentrate prices (per gram) declining from $18 for live resin in Q3 2023 to $11 in Q4 2025. Price stabilization has improved retailer margins. Average dispensary gross margins expanded from 38% in 2023 to 44% in 2025, according to confidential financial data compiled by MdCIA and shared with the General Assembly's budget committees. However, operators note that § 280E restrictions—which disallow deductions for cost of goods sold beyond direct cultivation expenses—reduce effective net margins to 12–18% for vertically integrated operators.

MSO Consolidation Trends

Multi-state operators have pursued aggressive acquisition strategies in Maryland. Trulieve's 2021 acquisition of Harvest Health valued Maryland licenses at approximately $8 million per dispensary, a premium reflecting the state's capped licensing regime. Curaleaf acquired Grassroots Cannabis in 2020 for $875 million, gaining eight Maryland dispensaries. Verano's 2019 acquisition of Harvest of Maryland (unrelated to Harvest Health) established its cultivation footprint. Independent operators face capital access challenges. The median independent dispensary generated $4.2 million in annual revenue during 2025, compared to $6.8 million for MSO-operated locations, according to MCA license renewal financial disclosures. This revenue gap reflects MSO advantages in brand recognition, supply chain integration, and marketing budgets.

Social Equity License Performance

Social equity dispensaries underperform financially relative to established operators. The median social equity dispensary generated $2.1 million in revenue during its first 12 months of operation, compared to $5.4 million for non-equity licensees, according to a March 2026 report by the Maryland Department of Commerce. Equity operators cite undercapitalization, limited access to real estate in high-traffic locations, and difficulty securing wholesale supply agreements as primary challenges. The Cannabis Business Assistance Fund disbursed $4.2 million in loans to 18 social equity applicants during fiscal year 2025, with loan amounts ranging from $150,000 to $500,000 at 3% interest rates. However, advocates note that typical dispensary build-out costs range from $800,000 to $1.5 million, requiring equity applicants to secure additional private capital—a challenge given federal banking restrictions and risk-averse private lenders.

Employment and Wages

Maryland's cannabis industry employed approximately 8,500 workers as of December 2025, according to Maryland Department of Labor data. Median wages by role:

Position	Median Annual Wage	Number of Workers
Budtender	$35,000	3,200
Cultivation Technician	$48,000	2,100
Extraction Technician	$52,000	680
Compliance Manager	$72,000	340
Dispensary Manager	$68,000	410
Master Grower	$95,000	85

Unionization efforts have gained traction: the United Food and Commercial Workers (UFCW) Local 27 represents workers at 14 Maryland dispensaries as of April 2026, negotiating contracts that include health benefits, paid sick leave, and profit-sharing provisions.

What Experts Say

Industry analysts, policymakers, and advocates offer divergent assessments of Maryland's program performance and future trajectory. According to Cynthia Boersma, MCA Executive Director, the agency prioritizes "building a sustainable, equitable market that serves patients and adult consumers while creating pathways for communities harmed by prohibition," as she stated during testimony before the Senate Finance Committee in February 2026. Boersma noted that the MCA conducted 2,640 compliance inspections during fiscal year 2025, issuing 87 notices of violation and suspending two licenses for diversion to unlicensed markets. Delegate Jazz Lewis, chair of the House Economic Matters Committee and lead sponsor of the 2023 implementing legislation, emphasized that "Maryland's social equity framework represents the most comprehensive in the nation, but implementation challenges require ongoing legislative attention," according to remarks at the MdCIA annual conference in March 2026. Lewis introduced House Bill 1205 in the 2026 session, which would create a $5 million grant program for social equity technical assistance, though the bill remained in committee as of May 2026. Olivia Naugle, policy analyst at the Marijuana Policy Project, argued that "Maryland's prohibition on home cultivation undermines the equity goals of legalization, forcing consumers—particularly those in underserved areas without nearby dispensaries—to participate in the regulated market or face continued criminalization," in an April 2026 policy brief. Naugle cited data showing that 22% of Maryland counties have zero licensed dispensaries, requiring residents to travel over 30 miles for legal access. Dr. Leana Wen, former Baltimore City Health Commissioner and current public health professor at George Washington University, cautioned that "Maryland must invest cannabis tax revenue in evidence-based prevention programs, particularly given data showing 12% of Maryland high school students reported past-month cannabis use in 2024, up from 9% in 2022," according to testimony before the House Health and Government Operations Committee in January 2026. Bruce Bereano, lobbyist representing several MSOs in Maryland, stated that "the current licensing cap creates artificial scarcity that benefits incumbent operators but limits consumer choice and maintains elevated prices," during a Maryland Cannabis Commission public hearing in November 2025. Bereano advocated for transitioning to an open licensing system similar to Oklahoma's, though equity advocates countered that such systems disadvantage small operators.

What's Next

Maryland's cannabis program faces several critical decision points and policy debates over the next 18 months, shaped by federal rescheduling, social equity implementation, and market maturation.

Federal Rescheduling Impact (Q3 2026)

The DEA's anticipated rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act, expected by September 2026, will eliminate § 280E tax restrictions for Maryland operators. Industry analysts project that § 280E relief could improve operator net margins by 8–12 percentage points, potentially reducing retail prices by 5–10% as competition intensifies. However, rescheduling will not resolve fundamental federal illegality, meaning banking access and interstate commerce restrictions will persist.

Social Equity License Lottery (Fall 2026)

The MCA plans to conduct a second social equity license lottery in October 2026, issuing up to 25 new dispensary licenses and 10 cultivation licenses exclusively to social equity applicants. The application period opens June 1, 2026, with a $1,000 non-refundable application fee (waived for applicants demonstrating financial hardship). Advocates have called for geographic distribution requirements to ensure licenses reach underserved counties.

Home Cultivation Debate (2027 Legislative Session)

Delegate Lewis has indicated plans to introduce home cultivation legislation during the 2027 General Assembly session, permitting adults to grow up to six plants per household. Similar bills failed in 2024 and 2025, facing opposition from the MdCIA (citing concerns about diversion to unlicensed markets) and law enforcement groups. Polling conducted by Gonzales Research in March 2026 showed 58% of Maryland adults support home cultivation, suggesting potential political viability.

Interstate Commerce Prospects (2027–2028)

If federal rescheduling proceeds and the Dormant Commerce Clause challenges to state residency requirements succeed in federal courts—as anticipated following oral arguments in Lowe's Market v. New Mexico Regulation and Licensing Department (10th Cir., argued March 2026)—Maryland may face pressure to permit interstate cannabis commerce. Such a shift would dramatically reshape the state's market, potentially allowing lower-cost imports from cultivation-heavy states like Oklahoma and Michigan while opening export opportunities for Maryland's established processors.

Consumption Lounge Expansion (2026–2027)

Baltimore City issued its first three on-site consumption licenses in February 2026, with facilities opening in the Fells Point, Hampden, and Station North neighborhoods. Early revenue data will inform decisions by other jurisdictions: Montgomery County and Howard County have scheduled ballot referendums on consumption lounges for November 2026. Industry projections suggest consumption lounges could generate $40–60 million in annual statewide revenue by 2028 if adopted broadly.

Further Reading

• Maryland Cannabis Administration official website: https://health.maryland.gov/cannabis
• Maryland Code, Health-General Article § 36-101 et seq. (cannabis regulatory statute): https://mgaleg.maryland.gov/mgawebsite/Laws/StatuteText?article=ghg§ion=36-101
• Question 4 (2022) constitutional amendment text: https://elections.maryland.gov/elections/2022/Constitutional_Amendments_2022.pdf
• Senate Bill 516 (2023) implementing legislation: https://mgaleg.maryland.gov/2023RS/bills/sb/sb0516E.pdf
• Maryland Cannabis Industry Association: https://www.mdcannabis.org
• Community Reinvestment and Repair Fund annual report (2025): https://commerce.maryland.gov/Documents/ResearchDocument/CRRFAnnualReport2025.pdf
• ACLU of Maryland cannabis enforcement disparities report (Q1 2026): https://www.aclu-md.org/en/cannabis-enforcement-2026
• Maryland Comptroller cannabis tax revenue dashboard: https://www.marylandtaxes.gov/cannabis-revenue
• BDSA Maryland cannabis market analytics (subscription required): https://www.bdsa.com/maryland
• Marijuana Policy Project Maryland legalization guide: https://www.mpp.org/states/maryland

Update — June 17, 2026: Maryland Reports $26.2M in Quarterly Cannabis Tax Revenue

Maryland collected $26.2 million in cannabis tax revenue during the most recent quarter, according to the Maryland Association of Counties. Local governments received $342,000 from the state's cannabis tax distribution formula. The quarterly figure reflects continued growth in the state's adult-use market, which launched in July 2023 following voter approval of Question 4 in November 2022.

The distribution to counties represents the state's revenue-sharing mechanism under the Cannabis Reform Act. Maryland law allocates a portion of the 9% retail sales tax to local jurisdictions based on where sales occur, with additional funds directed to the Community Reinvestment and Repair Fund and the Cannabis Business Assistance Fund. The $342,000 local share provides municipalities funding for public safety, infrastructure, and community programs in areas hosting licensed dispensaries.

The quarterly collection rate suggests Maryland is on pace to exceed $100 million in annual cannabis tax revenue if current trends continue. This revenue stream has become a significant component of state and local budgets, supporting regulatory oversight by the Cannabis Administration and funding social equity initiatives. Operators face the combined burden of the state retail tax, local jurisdiction fees, and federal 280E tax restrictions that prohibit standard business deductions.

For license holders, sustained tax collections indicate stable consumer demand and market maturation. The figures also inform investor projections for Maryland-based multi-state operators and vertically integrated licensees. Local governments' growing reliance on cannabis revenue creates fiscal incentives for municipalities to approve additional dispensary locations, potentially accelerating market saturation in high-population counties.